Release‐enhancing pre‐synaptic muscarinic and nicotinic receptors co‐exist and interact on dopaminergic nerve endings of rat nucleus accumbens

Neuronal Calcium Signaling

Berridge, M. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80510-3 · Cited by 2,189 · see citing works

Presynaptic nicotinic ACh receptors

Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works

Muscarinic Receptors—Characterization, coupling and function

Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277 · see citing works

Pirenzepine distinguishes between different subclasses of muscarinic receptors

Hammer, R., Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V., & Hulme, E. C. (1980) · Nature · doi:10.1038/283090a0 · Cited by 1,273 · see citing works

Elementary and global aspects of calcium signalling.

Berridge, M. J. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021927 · Cited by 1,017 · see citing works

Modulation of neurotransmitter release by presynaptic autoreceptors

Starke, K., Göthert, M., & Kilbinger, H. J. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.864 · Cited by 927 · see citing works

Brain nicotinic acetylcholine receptors: native subtypes and their relevance

Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works

Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor

Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., & Pessah, I. N. (1997) · Neuron · doi:10.1016/s0896-6273(00)80384-0 · Cited by 589 · see citing works

Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum

Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585 · see citing works

International Union of Pharmacology. XX. Current Status of the Nomenclature for Nicotinic Acetylcholine Receptors and Their Subunits

Lukas, R. J., Changeux, J., Novère, N. G. L., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01406-6 · Cited by 536 · see citing works

Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works

Molecular Biology of Muscarinic Acetylcholine Receptors

Wess, J. (1996) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.40 · Cited by 491 · see citing works

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Weiner, D. M., Levey, A. I., & Brann, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7050 · Cited by 481 · see citing works

Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice

Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works

Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain

Raiteri, M., Leardi, R., & Marchi, M. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21528-2 · Cited by 314 · see citing works

A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes

Watson, M., Yamamura, H. I., & Roeske, W. R. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90652-5 · Cited by 295 · see citing works

Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry

Vilaró, M. T., Palacios, J., & Mengod, G. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90064-g · Cited by 269 · see citing works

Nicotine: from molecular mechanisms to behaviour

Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works

Synthesis and characterization of antagonists of cyclic-ADP-ribose-induced Ca2+ release

Walseth, T. F., & Lee, H. C. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90199-y · Cited by 262 · see citing works

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works

Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M₁–M₅Muscarinic Receptor Knock-Out Mice

Zhang, W., Yamada, M., Gomeza, J., Basile, A. S., & Wess, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06347.2002 · Cited by 224 · see citing works

Synaptosomes Still Viable after 25 Years of Superfusion

Raiteri, L., & Raiteri, M. (2000) · Neurochemical Research · doi:10.1023/a:1007648229795 · Cited by 206 · see citing works

α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes

Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198 · see citing works

Presynaptic localisation of the nicotinic acetylcholine receptor β2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones

Jones, I. W., Bolam, J. P., & Wonnacott, S. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1345 · Cited by 167 · see citing works

UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes

Sharples, C. G. V., Kaiser, S., Soliakov, L. S., Marks, M. J., Collins, A. C., Washburn, M. S., Wright, E., Spencer, J. A., Gallagher, T., Whiteaker, P., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02783.2000 · Cited by 164 · see citing works

Movement of ‘gating charge’ is coupled to ligand binding in a G-protein-coupled receptor

Ben-Chaim, Y., Chanda, B., Dascal, N., Bezanilla, F., Parnas, I., & Parnas, H. (2006) · Nature · doi:10.1038/nature05259 · Cited by 164 · see citing works

25 Years since the discovery of presynaptic receptors: present knowledge and future perspectives

Langer, S. Z. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01034-6 · Cited by 164 · see citing works

Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum

Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156 · see citing works

Methyllycaconitine Is a Potent Antagonist of α-Conotoxin-MII-Sensitive Presynaptic Nicotinic Acetylcholine Receptors in Rat Striatum

Mogg, A. J., Whiteaker, P., McIntosh, J. M., Marks, M. J., Collins, A. C., & Wonnacott, S. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.197 · Cited by 146 · see citing works

RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

Bencherif, M., Lovette, M. E., Fowler, K., Arrington, S. R., Reeves, L., Caldwell, W. S., & Lippiello, P. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21302-7 · Cited by 141 · see citing works

Novel insights into muscarinic acetylcholine receptor function using gene targeting technology

Wess, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00195-0 · Cited by 139 · see citing works

Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine

Lehmann, J. C., & Langer, S. Z. (1982) · Brain Research · doi:10.1016/0006-8993(82)91147-7 · Cited by 138 · see citing works

Nonsynaptic communication in the central nervous system

Vizi, E. S., Kiss, J., & Lendvai, B. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.016 · Cited by 128 · see citing works

Role for M 5 muscarinic acetylcholine receptors in cocaine addiction

Fink‐Jensen, A., Fedorova, I. D., Wörtwein, G., Woldbye, D. P. D., Rasmussen, T., Thomsen, M., Bolwig, T. G., Knitowski, K. M., McKinzie, D. L., Yamada, M., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10728 · Cited by 127 · see citing works

Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy

Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works

The muscarinic M 5 receptor: a silent or emerging subtype?

Eglen, R. M., & Nahorski, S. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703276 · Cited by 121 · see citing works

Reduced Cocaine Self-Administration in Muscarinic M5Acetylcholine Receptor-Deficient Mice

Thomsen, M., Woldbye, D. P. D., Wörtwein, G., Fink‐Jensen, A., Wess, J., & Caine, S. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2077-05.2005 · Cited by 119 · see citing works

Autoregulation of acetylcholine release in isolated hippocampal nerve endings

Marchi, M., Paudice, P., & Raiteri, M. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90147-3 · Cited by 103 · see citing works

Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus.

Kemel, M. L., Desban, M., Glowinski, J., & Gauchy, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9006 · Cited by 92 · see citing works

Presynaptic muscarinic receptors increase striatal dopamine release evoked by ‘quasi-physiological’ depolarization

Raiteri, M., Marchi, M., & Maura, G. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90296-5 · Cited by 77 · see citing works

Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology

Yamada, M., Basile, A. S., Fedorova, I. D., Zhang, W., Duttaroy, A., Cui, Y., Lamping, K. G., Faraci, F. M., Deng, C., & Wess, J. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.022 · Cited by 74 · see citing works

Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine

Schoffelmeer, A. N. M., Vliet, B. J. V., Wardeh, G., et al. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90781-8 · Cited by 71 · see citing works

Functional Pharmacology in Human Brain

Raiteri, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.5 · Cited by 68 · see citing works

The Activation and Inhibition of Human Nicotinic Acetylcholine Receptor by RJR‐2403 Indicate a Selectivity for the α4β2 Receptor Subtype

Papke, R. L., Webster, J. C., Lippiello, P. M., Bencherif, M., & Francis, M. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750204.x · Cited by 63 · see citing works

Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats

Mark, G. P., Kinney, A. E. “., Grubb, M. C., Zhu, X., Finn, D. A., Mader, S. L., Berger, S. P., & Bechtholt, A. J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.029 · Cited by 28 · see citing works

Oxytocin pathway gene networks in the human brain

Quintana, D. S., Rokicki, J., van der Meer, D., Alnæs, D., Kaufmann, T., Córdova-Palomera, A., Dieset, I., Andreassen, O. A., & Westlye, L. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08503-8 · Cited by 354 · see citing works

Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways

Silveira, M. M., Malcolm, E., Shoaib, M., & Winstanley, C. A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.029 · Cited by 31 · see citing works

Nicotinic Receptor Systems and Neurobehavioral Function in Zebrafish

Levin, E. D. (2010) · Neuromethods · doi:10.1007/978-1-60761-922-2_4 · Cited by 1 · see citing works

Differential Effect of Nicotinic Agonists on the [3H]Norepinephrine Release from Rat Hippocampal Slices

Kiss, J., Windisch, K., Oliveira, K. D., Hennings, E. C. P., Mike, Á., & Szász, B. K. (2001) · Neurochemical Research · doi:10.1023/a:1012384517784 · Cited by 13 · see citing works

Nicotine-improved aspects of psychomotor performance and cognitive ability: Fact or fiction

Hindmarch, I. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)86341-9

Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.

Roth, K. A., McIntire, S. L., & Barchas, J. D. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33075-2 · Cited by 39 · see citing works

A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques

Mulle, C., & Changeux, J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00169.1990 · Cited by 107 · see citing works